| 中文名称 |
EsculentosideA
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 中文别名 |
商陆皂苷甲;商陆皂甙甲;商陆皂甙A;商陆种苷A;商陆皂甙;商陆皂苷甲(标准品);商陆皂苷A;商陆皂甙A、商陆种苷A、商陆皂甙甲;商陆皂苷甲 标准品;商陆皂苷甲 商陆皂苷A;商陆皂苷甲(商陆皂甙A);商陆皂苷甲(商陆皂甙A、商陆种苷A、商陆皂甙甲);商陆皂苷甲,Esculentoside A,植物提取物,标准品,对照品;商陆皂苷甲对照品;商路皂苷甲;商陆皂苷甲,Esculentoside A;商陆皂苷甲,商陆皂甙A
|
|||||||||
| 英文名称 |
EsculentosideA
|
|||||||||
| 英文别名 |
Esculentoside A;(2b,3b,4a,20b)-3-((4-O-beta-D-Glucopyranosyl-beta-D-xylopyranosyl)oxy)-2,23-dihydroxyolean-12-ene-28,29-dioic acid 29-methyl ester;PHYTOLACCOSIDE E;Esculentoside;Phytolacaponin E;Phytolaccasaponin E
|
|||||||||
| Cas No. |
65497-07-6
|
|||||||||
| 分子式 |
C42H66O16
|
|||||||||
| 分子量 |
826.96
|
|||||||||
| 包装储存 |
|
|||||||||
| 详情描述 |
Esculentoside A (EsA),一种从商陆 Phytolacca esculenta 根部分离出来的三萜皂苷。Esculentoside A (EsA) 在具有抗炎活性,对环氧合酶-2 (COX-2) 具有选择性抑制活性。Esculentoside A (EsA) 通过抑制 (NF-ΚB) 和丝裂原活化蛋白激酶 (MAPK) 信号通路抑制 LPS 诱导的急性肺损伤 (ALI) 中的炎症反应。
|
| 生物活性 |
Esculentoside A (EsA), a kind of triterpene saponin isolated from roots of Phytolacca esculenta. Esculentoside A (EsA) possesses anti-inflammatory activity in acute and chronic experimental models, has selective inhibitory activity towards cyclooxygenase-2 (COX-2). Esculentoside A (EsA) suppresses inflammatory responses in LPS-induced acute lung injury (ALI) through inhibition of the nuclear factor kappa B (NF-ΚB) and mitogen activated protein kinase (MAPK) signaling pathways. |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 性状 |
Solid |
|||||||||
| 体外研究(In Vitro) |
Esculentoside A (0-10 μM; 24 hours) reduced the release of TNF concentration in primed macrophages . Medlife has not independently confirmed the accuracy of these methods. They are for reference only. |
|||||||||
| 体内研究(In Vivo) |
Esculentoside A (EsA) (intraperitoneal injection; 20 mg/kg; once a day; 4 weeks) plays significant roles in the treatment of BXSB mice through modulation of inflammatory cytokines, inhibition of renal cell proliferation and induction of apoptosis . Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
|
|||||||||
| 运输条件 |
Room temperature or refrigerated transportation. |
|||||||||
| 储存方式 |
|
|||||||||
| 结构分类 | ||||||||||
| 来源 | ||||||||||
| 参考文献 |
|
| 溶解度数据 |
体外研究:
DMSO : 100 mg/mL (120.92 mM; Need ultrasonic) 配制储备溶液
*
产品不同,其溶解度不同。建议根据产品选择合适的溶剂配制储备溶液;配成溶液后,建议分装保存,避免反复冻融造成的产品失效。 体内研究:
建议根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都建议先按照 体外研究 方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
*
|
|---|
[1]. Wu F, et al. Synthesis, 体外研究 inhibitory activity towards COX-2 and haemolytic activity of derivatives of esculentoside A. Bioorg Med Chem Lett. 2007 Dec 1;17(23):6430-3. Epub 2007 Oct 5. [Information]
[2]. Ma H, et al. The effect of esculentoside A on lupus nephritis-prone BXSB mice. Arch Med Sci. 2013 Apr 20;9(2):354-60. [Information]
[4]. Ju DW, et al. Esculentoside A inhibits tumor necrosis factor, interleukin-1, and interleukin-6 production induced by lipopolysaccharide in mice. Pharmacology. 1998 Apr;56(4):187-95 [Information]
1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。
2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。
Copyright © 2025 陌孚医药 All rights reserved 未经授权禁止拷贝本站所有资料,如有违反,将追究法律责任。
沪ICP备2023012080号 |
沪公网安备31011402010657号
扫码关注公众号